BlackRock »

Adicet Bio Ord shares owned by BlackRock

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by BlackRock

Quarter filed Position value Share count Share price at filing
2025-12-31 $308k 37k 8.42

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)

View all positions for BlackRock

Top funds holding Adicet Bio Ord

OrbiMed Advisors
RA Capital Management
Franklin Resources
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Two Sigma Investments
ADAR1 Capital Management

View all funds holding Adicet Bio Ord